Prostaglandin Analog [EPC]

Prostaglandin Analog [EPC] was reported 93118 times

Drugs of the Prostaglandin Analog [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 IRIS HYPERPIGMENTATION 147 0.7067
1 BLEPHARAL PIGMENTATION 325 0.6436
2 GROWTH OF EYELASHES 459 0.5795
3 EYELASH THICKENING 68 0.5667
4 EYELASH CHANGES 82 0.4633
5 INTRAOCULAR PRESSURE FLUCTUATION 82 0.4162
6 UTERINE HYPERSTIMULATION 41 0.4020
7 MALIGNANT MEDIASTINAL NEOPLASM 42 0.3818
8 EYELASH DISCOLOURATION 78 0.3562
9 GLAUCOMA SURGERY 62 0.2422
10 INTRAOCULAR PRESSURE TEST ABNORMAL 170 0.2411
11 PRODUCT DROPPER ISSUE 183 0.2325
12 INTRAOCULAR PRESSURE INCREASED 2921 0.2283
13 ERYTHEMA OF EYELID 1230 0.2269
14 SCLERAL HYPERAEMIA 154 0.2261
15 LID SULCUS DEEPENED 79 0.2118
16 INTRAOCULAR PRESSURE DECREASED 111 0.2106
17 TRICHIASIS 66 0.2075
18 EYELIDS PRURITUS 640 0.2052
19 EYELID IRRITATION 498 0.1983
20 PRODUCT CLOSURE REMOVAL DIFFICULT 200 0.1961
21 OCULAR SURFACE DISEASE 52 0.1851
22 EYELID THICKENING 50 0.1754
23 STEROID DEPENDENCE 148 0.1686
24 CATARRH 148 0.1637
25 OPEN ANGLE GLAUCOMA 97 0.1580
26 REACTION TO PRESERVATIVES 123 0.1511
27 EYELID EXFOLIATION 112 0.1418
28 EYE COLOUR CHANGE 137 0.1346
29 MADAROSIS 1489 0.1282
30 CHOROIDAL DETACHMENT 69 0.1243
31 HYPOTONY OF EYE 52 0.1238
32 EYELID PAIN 243 0.1195
33 DARK CIRCLES UNDER EYES 164 0.1114
34 FOREIGN BODY SENSATION IN EYES 693 0.1086
35 IRIS DISORDER 58 0.1078
36 GLAUCOMA 1991 0.1033
37 TRICHORRHEXIS 282 0.1010
38 OCULAR HYPERAEMIA 4772 0.1005
39 TREATMENT FAILURE 8071 0.0973
40 EYE LASER SURGERY 57 0.0964
41 HYPHAEMA 49 0.0939
42 EYE IRRITATION 5257 0.0912
43 BURNS SECOND DEGREE 157 0.0894
44 EYE BURNS 49 0.0832
45 CORNEAL OEDEMA 185 0.0825
46 CONJUNCTIVAL HYPERAEMIA 292 0.0818
47 EYELID MARGIN CRUSTING 235 0.0812
48 EYELID RASH 77 0.0787
49 EYE ALLERGY 121 0.0781
50 CHOROIDAL EFFUSION 62 0.0772
51 INSTILLATION SITE ERYTHEMA 40 0.0758
52 EYE PRURITUS 2530 0.0752
53 BLEPHARITIS 301 0.0750
54 EYELID DISORDER 169 0.0732
55 CORNEAL OPACITY 100 0.0732
56 EYELID SKIN DRYNESS 88 0.0725
57 PAINFUL ERECTION 49 0.0711
58 PRODUCT CONTAINER SEAL ISSUE 122 0.0700
59 SUPERFICIAL INJURY OF EYE 75 0.0686
60 PUNCTATE KERATITIS 62 0.0675
61 CORNEAL DISORDER 148 0.0674
62 CYSTOID MACULAR OEDEMA 123 0.0652
63 PERIORBITAL PAIN 55 0.0649
64 PRODUCT CONTAINER ISSUE 548 0.0639
65 FOREIGN BODY IN EYE 59 0.0615
66 EYE DISCHARGE 636 0.0611
67 EYE PAIN 3438 0.0609
68 SKIN HYPERPIGMENTATION 523 0.0608
69 ABNORMAL SENSATION IN EYE 255 0.0593
70 PRODUCT DESIGN ISSUE 41 0.0573
71 CORNEAL DEPOSITS 42 0.0565
72 OCULAR HYPERTENSION 107 0.0551
73 OCULAR DISCOMFORT 604 0.0537
74 EYELID OEDEMA 609 0.0523
75 HYPOPNOEA 170 0.0489
76 PRODUCT DELIVERY MECHANISM ISSUE 262 0.0487
77 OCULAR VASCULAR DISORDER 40 0.0485
78 INSTILLATION SITE PAIN 117 0.0472
79 IRITIS 138 0.0453
80 OPTIC NERVE INJURY 52 0.0448
81 SWELLING OF EYELID 263 0.0418
82 RED BLOOD CELLS URINE POSITIVE 40 0.0414
83 CATARACT OPERATION 245 0.0412
84 CORNEAL ABRASION 56 0.0408
85 CONJUNCTIVITIS ALLERGIC 60 0.0405
86 PRODUCT PACKAGE ASSOCIATED INJURY 89 0.0399
87 ALCOHOL POISONING 105 0.0392
88 INCISION SITE PAIN 46 0.0391
89 INSTILLATION SITE IRRITATION 45 0.0380
90 OPTIC NERVE DISORDER 60 0.0375
91 ASTHENOPIA 201 0.0365
92 BRONCHIECTASIS 240 0.0356
93 HAIR GROWTH ABNORMAL 243 0.0351
94 LACRIMATION INCREASED 1058 0.0350
95 EYE INFLAMMATION 329 0.0344
96 ULCERATIVE KERATITIS 94 0.0343
97 VISUAL FIELD DEFECT 247 0.0341
98 EYE SWELLING 1250 0.0336
99 MACULAR HOLE 45 0.0335
100 VISUAL ACUITY REDUCED 1100 0.0331
101 DRY EYE 1648 0.0330
102 PHOTOPHOBIA 619 0.0329
103 HORDEOLUM 142 0.0328
104 ERECTION INCREASED 136 0.0325
105 ANGLE CLOSURE GLAUCOMA 81 0.0317
106 CATARACT 1861 0.0312
107 EYE OPERATION 144 0.0312
108 PREMATURE SEPARATION OF PLACENTA 48 0.0312
109 BLINDNESS UNILATERAL 431 0.0305
110 INCORRECT STORAGE OF DRUG 52 0.0301
111 EYE DISORDER 987 0.0300
112 PENILE PAIN 91 0.0299
113 MACULAR OEDEMA 159 0.0283
114 PRODUCT PACKAGING DIFFICULT TO OPEN 74 0.0283
115 EYE INJURY 86 0.0283
116 RETINAL DISORDER 73 0.0280
117 COLITIS MICROSCOPIC 132 0.0278
118 EYE OEDEMA 68 0.0277
119 EYE INFECTION 312 0.0276
120 KERATITIS 82 0.0269
121 PAROSMIA 202 0.0267
122 RHINITIS 203 0.0252
123 IRIDOCYCLITIS 78 0.0247
124 PRIAPISM 85 0.0246
125 METAMORPHOPSIA 45 0.0244
126 GINGIVAL PAIN 194 0.0244
127 HYPERPARATHYROIDISM SECONDARY 58 0.0231
128 MEDICAL DEVICE REMOVAL 40 0.0231
129 ESSENTIAL HYPERTENSION 42 0.0229
130 NEPHROGENIC ANAEMIA 105 0.0226
131 CARDIAC MURMUR 194 0.0224
132 RETINAL TEAR 55 0.0223
133 PERIORBITAL SWELLING 125 0.0221
134 VITREOUS HAEMORRHAGE 61 0.0221
135 CONJUNCTIVAL HAEMORRHAGE 84 0.0220
136 HYPERAEMIA 42 0.0213
137 VITREOUS DETACHMENT 46 0.0212
138 VISION BLURRED 2907 0.0212
139 BLOOD IMMUNOGLOBULIN E INCREASED 51 0.0210
140 RETINAL VEIN OCCLUSION 57 0.0198
141 MACULAR DEGENERATION 230 0.0192
142 RETINAL DETACHMENT 174 0.0189
143 BODY HEIGHT DECREASED 202 0.0189
144 BLINDNESS 764 0.0187
145 VITREOUS FLOATERS 183 0.0186
146 EYE HAEMORRHAGE 246 0.0184
147 EXPIRED DRUG ADMINISTERED 91 0.0184
148 PRODUCT PACKAGING ISSUE 170 0.0179
149 PENIS DISORDER 40 0.0161
150 PRODUCT USE COMPLAINT 246 0.0156
151 DRUG ADMINISTERED AT INAPPROPRIATE SITE 164 0.0155
152 EYELID PTOSIS 153 0.0150
153 CONJUNCTIVITIS 278 0.0150
154 BLINDNESS TRANSIENT 110 0.0149
155 VISUAL IMPAIRMENT 1808 0.0146
156 PERIPHERAL VASCULAR DISORDER 75 0.0145
157 PIGMENTATION DISORDER 88 0.0142
158 MACULOPATHY 50 0.0141
159 PHOTOPSIA 89 0.0141
160 LIQUID PRODUCT PHYSICAL ISSUE 102 0.0140
161 IMPAIRED QUALITY OF LIFE 190 0.0132
162 HEARING IMPAIRED 79 0.0132
163 UVEITIS 178 0.0131
164 WRONG TECHNIQUE IN DRUG USAGE PROCESS 474 0.0130
165 POOR QUALITY PRODUCT ADMINISTERED 131 0.0124
166 SKIN DISCOLOURATION 561 0.0122
167 MENISCUS INJURY 75 0.0122
168 TUBULOINTERSTITIAL NEPHRITIS 227 0.0121
169 ATRIAL FLUTTER 94 0.0118
170 HAEMORRHAGIC ANAEMIA 51 0.0116
171 PRODUCT PHYSICAL CONSISTENCY ISSUE 64 0.0116
172 BLEPHAROSPASM 72 0.0114
173 PRODUCT FORMULATION ISSUE 75 0.0114
174 HYPERSENSITIVITY 2106 0.0113
175 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 46 0.0113
176 EPIGASTRIC DISCOMFORT 44 0.0113
177 BENIGN PROSTATIC HYPERPLASIA 58 0.0112
178 THYROID DISORDER 173 0.0112
179 POOR QUALITY DRUG ADMINISTERED 71 0.0110
180 TOXIC EPIDERMAL NECROLYSIS 165 0.0109
181 FULL BLOOD COUNT ABNORMAL 113 0.0107
182 PRODUCT LABEL ISSUE 72 0.0106
183 RETINAL HAEMORRHAGE 75 0.0105
184 ENDOPHTHALMITIS 63 0.0105
185 SEASONAL ALLERGY 148 0.0104
186 HEART RATE ABNORMAL 58 0.0104
187 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 737 0.0103
188 DIPLOPIA 266 0.0102
189 PROSTATOMEGALY 40 0.0102
190 BLOOD MAGNESIUM DECREASED 87 0.0101
191 NEUTROPHIL COUNT INCREASED 103 0.0100
192 GOITRE 41 0.0100
193 EXPIRED PRODUCT ADMINISTERED 331 0.0099
194 EAR DISORDER 45 0.0098
195 EXTRASYSTOLES 67 0.0096
196 VISUAL DISTURBANCE 55 0.0096
197 RENAL CYST 76 0.0096
198 SWOLLEN TONGUE 298 0.0095
199 PRODUCT LEAKAGE 53 0.0094
200 FREQUENT BOWEL MOVEMENTS 255 0.0094
201 HYPOACUSIS 406 0.0094
202 PROTEIN URINE PRESENT 47 0.0094
203 HOSPICE CARE 93 0.0094
204 TINNITUS 429 0.0093
205 SKIN REACTION 130 0.0092
206 PHLEBITIS 47 0.0092
207 PRODUCT ADMINISTRATION ERROR 185 0.0091
208 DIVERTICULITIS 253 0.0091
209 UPPER-AIRWAY COUGH SYNDROME 75 0.0091
210 ANGIOPATHY 51 0.0091
211 SKIN LACERATION 98 0.0090
212 ATRIOVENTRICULAR BLOCK COMPLETE 60 0.0090
213 INCREASED UPPER AIRWAY SECRETION 46 0.0090
214 IRON DEFICIENCY ANAEMIA 82 0.0089
215 BLOOD UREA INCREASED 148 0.0088
216 INCORRECT PRODUCT STORAGE 116 0.0088
217 END STAGE RENAL DISEASE 160 0.0088
218 DIVERTICULUM 62 0.0087
219 PRODUCT RESIDUE PRESENT 47 0.0087
220 HYPERKERATOSIS 48 0.0087
221 PERIORBITAL OEDEMA 45 0.0087
222 SINUS DISORDER 169 0.0085
223 PROSTATIC DISORDER 47 0.0085
224 RENAL FAILURE CHRONIC 65 0.0084
225 HYPERLIPIDAEMIA 101 0.0084
226 DIZZINESS POSTURAL 81 0.0083
227 GROIN PAIN 73 0.0083
228 DYSLIPIDAEMIA 42 0.0083
229 CARDIAC PACEMAKER INSERTION 49 0.0082
230 NIGHTMARE 283 0.0082
231 PRODUCT QUALITY ISSUE 1110 0.0082
232 EMPHYSEMA 82 0.0081
233 BLOOD PRESSURE FLUCTUATION 195 0.0081
234 VERTIGO 495 0.0081
235 INTERVERTEBRAL DISC DEGENERATION 75 0.0081
236 ORTHOSTATIC HYPOTENSION 141 0.0081
237 IMPAIRED WORK ABILITY 173 0.0081
238 DRY THROAT 81 0.0080
239 NASAL DISCOMFORT 63 0.0079
240 LYMPHOCYTE COUNT DECREASED 140 0.0079
241 UPPER GASTROINTESTINAL HAEMORRHAGE 133 0.0079
242 SYNOVITIS 142 0.0079
243 LIMB INJURY 213 0.0078
244 PROSTATIC SPECIFIC ANTIGEN INCREASED 108 0.0078
245 HEART RATE IRREGULAR 177 0.0078
246 ARTHRITIS 615 0.0078
247 FACIAL PAIN 69 0.0077
248 MULTIPLE USE OF SINGLE-USE PRODUCT 43 0.0077
249 HALLUCINATION, VISUAL 161 0.0076
250 LOWER GASTROINTESTINAL HAEMORRHAGE 56 0.0076
251 ARTERIOSCLEROSIS CORONARY ARTERY 50 0.0075
252 LARGE INTESTINE POLYP 52 0.0075
253 NASAL DRYNESS 47 0.0075
254 ACCIDENTAL OVERDOSE 274 0.0075
255 DYSGEUSIA 556 0.0075
256 INFUSION SITE SWELLING 47 0.0075
257 RHINORRHOEA 482 0.0074
258 EYE MOVEMENT DISORDER 51 0.0074
259 RECTAL HAEMORRHAGE 318 0.0074
260 DERMATITIS CONTACT 84 0.0074
261 HEART RATE DECREASED 258 0.0073
262 ATRIAL FIBRILLATION 712 0.0073
263 HAEMOGLOBIN ABNORMAL 47 0.0073
264 DYSPNOEA EXERTIONAL 274 0.0073
265 ARRHYTHMIA 343 0.0072
266 BLOOD PRESSURE ABNORMAL 144 0.0072
267 ENCEPHALITIS 50 0.0072
268 NOCTURIA 87 0.0072
269 HAIR COLOUR CHANGES 89 0.0071
270 CAESAREAN SECTION 83 0.0071
271 ARTERIAL OCCLUSIVE DISEASE 56 0.0071
272 SCIATICA 113 0.0071
273 BURNING SENSATION 496 0.0071
274 HAIR DISORDER 58 0.0070
275 HIATUS HERNIA 91 0.0070
276 HAEMOGLOBIN DECREASED 717 0.0070
277 HYPONATRAEMIA 393 0.0070
278 SPUTUM DISCOLOURED 66 0.0070
279 BLOOD SODIUM DECREASED 131 0.0069
280 BRONCHITIS 514 0.0069
281 HYPERAESTHESIA 57 0.0069
282 OSTEOARTHRITIS 294 0.0069
283 DRUG ADMINISTRATION ERROR 212 0.0069
284 DEMENTIA 193 0.0069
285 VITAMIN D DECREASED 59 0.0069
286 HYPERKALAEMIA 242 0.0069
287 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 233 0.0069
288 TRANSIENT ISCHAEMIC ATTACK 232 0.0069
289 BRADYCARDIA 364 0.0069
290 HAIR TEXTURE ABNORMAL 91 0.0068
291 RESPIRATORY TRACT CONGESTION 108 0.0068
292 DYSPHONIA 397 0.0068
293 SUBDURAL HAEMATOMA 97 0.0068
294 SENSATION OF FOREIGN BODY 57 0.0068
295 CARDIAC FAILURE ACUTE 45 0.0067
296 DRUG INEFFECTIVE 8891 0.0067
297 GOUT 121 0.0067
298 BLOOD ALBUMIN DECREASED 53 0.0067
299 UPPER LIMB FRACTURE 133 0.0067
300 PULMONARY CONGESTION 88 0.0067
301 HEAD DISCOMFORT 118 0.0067
302 URINE OUTPUT DECREASED 58 0.0066
303 INTERNATIONAL NORMALISED RATIO INCREASED 189 0.0066
304 PEMPHIGOID 50 0.0066
305 GLOMERULAR FILTRATION RATE DECREASED 81 0.0066
306 ERECTILE DYSFUNCTION 169 0.0066
307 DELUSION 102 0.0066
308 DEAFNESS 171 0.0065
309 THERAPEUTIC RESPONSE DECREASED 396 0.0065
310 DYSGRAPHIA 43 0.0065
311 FALL 2171 0.0065
312 DUODENAL ULCER 46 0.0065
313 SINUS BRADYCARDIA 63 0.0065
314 CORONARY ARTERY DISEASE 197 0.0065
315 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 119 0.0065
316 TRANSFUSION 68 0.0065
317 THROAT IRRITATION 291 0.0065
318 BLOOD PRESSURE SYSTOLIC INCREASED 126 0.0065
319 DRY MOUTH 523 0.0064
320 WRIST FRACTURE 77 0.0064
321 TRICUSPID VALVE INCOMPETENCE 51 0.0064
322 ATELECTASIS 62 0.0064
323 BALANCE DISORDER 554 0.0064
324 ONYCHOCLASIS 44 0.0064
325 WALKING AID USER 42 0.0064
326 HALLUCINATION 480 0.0064
327 HAEMATOCRIT DECREASED 126 0.0063
328 SLEEP APNOEA SYNDROME 121 0.0063
329 PRODUCTIVE COUGH 302 0.0063
330 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 329 0.0063
331 INFUSION SITE ERYTHEMA 53 0.0063
332 EAR PAIN 122 0.0063
333 MYOSITIS 56 0.0062
334 WHEEZING 370 0.0062
335 BLOOD PRESSURE DIASTOLIC DECREASED 46 0.0062
336 ANAL INCONTINENCE 56 0.0062
337 HIP FRACTURE 200 0.0062
338 BASAL CELL CARCINOMA 97 0.0062
339 CARDIAC FAILURE CONGESTIVE 499 0.0062
340 PALPITATIONS 726 0.0062
341 RED BLOOD CELL COUNT DECREASED 176 0.0061
342 INFARCTION 42 0.0061
343 NASAL CONGESTION 360 0.0061
344 PRODUCT ADMINISTRATION INTERRUPTED 48 0.0061
345 CONFUSIONAL STATE 988 0.0061
346 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 293 0.0061
347 BLOOD PRESSURE DECREASED 404 0.0061
348 OSTEOPENIA 92 0.0061
349 VITAMIN D DEFICIENCY 59 0.0060
350 SCAB 69 0.0060
351 ACUTE RESPIRATORY FAILURE 116 0.0060
352 PRODUCT SUBSTITUTION ISSUE 347 0.0060
353 GASTROINTESTINAL INFECTION 54 0.0060
354 FACIAL PARALYSIS 51 0.0060
355 PULMONARY MASS 89 0.0060
356 OESOPHAGITIS 65 0.0059
357 PHOTOSENSITIVITY REACTION 98 0.0059
358 OBSTRUCTIVE AIRWAYS DISORDER 66 0.0059
359 BLOOD PRESSURE INCREASED 907 0.0059
360 LYMPHOEDEMA 41 0.0059
361 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 46 0.0059
362 SPINAL OSTEOARTHRITIS 52 0.0059
363 MEDICATION ERROR 329 0.0059
364 DIABETES MELLITUS 448 0.0059
365 DRUG INTOLERANCE 566 0.0059
366 HYPERTENSION 1241 0.0059
367 CHRONIC KIDNEY DISEASE 445 0.0059
368 HAEMATOCHEZIA 323 0.0058
369 BLOOD CHOLESTEROL INCREASED 270 0.0058
370 BLOOD POTASSIUM DECREASED 174 0.0058
371 PELVIC FRACTURE 45 0.0058
372 PRODUCT DOSE OMISSION IN ERROR 163 0.0058
373 BOWEL MOVEMENT IRREGULARITY 44 0.0057
374 MITRAL VALVE INCOMPETENCE 65 0.0057
375 FULL BLOOD COUNT DECREASED 115 0.0057
376 ACUTE KIDNEY INJURY 873 0.0057
377 AGEUSIA 142 0.0057
378 ATRIOVENTRICULAR BLOCK 44 0.0057
379 VENTRICULAR EXTRASYSTOLES 59 0.0057
380 SYNCOPE 568 0.0057
381 SNEEZING 127 0.0057
382 POLLAKIURIA 236 0.0057
383 AORTIC ANEURYSM 43 0.0056
384 DECUBITUS ULCER 46 0.0056
385 ARTERIOSCLEROSIS 53 0.0056
386 POLYURIA 46 0.0056
387 DEEP VEIN THROMBOSIS 365 0.0056
388 TOOTH INFECTION 74 0.0056
389 MULTIPLE ALLERGIES 44 0.0056
390 ERYTHEMA 1153 0.0056
391 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1135 0.0056
392 PULMONARY OEDEMA 250 0.0056
393 PRODUCT AVAILABILITY ISSUE 127 0.0056
394 TASTE DISORDER 113 0.0056
395 MIDDLE INSOMNIA 104 0.0056
396 HAEMORRHAGE INTRACRANIAL 83 0.0055
397 INCREASED TENDENCY TO BRUISE 51 0.0055
398 ORAL PAIN 124 0.0055
399 HAEMORRHOIDS 108 0.0055
400 FAECES DISCOLOURED 120 0.0055
401 CARDIOMEGALY 68 0.0055
402 UROSEPSIS 51 0.0055
403 PLATELET COUNT INCREASED 72 0.0055
404 ELECTROLYTE IMBALANCE 64 0.0055
405 HAEMORRHAGIC STROKE 43 0.0055
406 URINARY TRACT INFECTION 939 0.0055
407 GENERALISED OEDEMA 68 0.0055
408 HYPOKALAEMIA 253 0.0055
409 BEDRIDDEN 72 0.0055
410 EXOSTOSIS 50 0.0055
411 BLOOD CALCIUM INCREASED 48 0.0055
412 MYDRIASIS 70 0.0055
413 EAR DISCOMFORT 56 0.0055
414 RESPIRATORY TRACT INFECTION 142 0.0054
415 MALIGNANT MELANOMA 73 0.0054
416 RIB FRACTURE 112 0.0054
417 HEAD INJURY 172 0.0054
418 LOW DENSITY LIPOPROTEIN INCREASED 42 0.0054
419 CONCUSSION 42 0.0054
420 C-REACTIVE PROTEIN INCREASED 197 0.0054
421 PULMONARY THROMBOSIS 59 0.0054
422 SINUS CONGESTION 73 0.0054
423 EPISTAXIS 404 0.0054
424 BLOOD URINE PRESENT 102 0.0054
425 ROTATOR CUFF SYNDROME 69 0.0054
426 BLADDER DISORDER 53 0.0053
427 ECZEMA 279 0.0053
428 PULMONARY HYPERTENSION 111 0.0053
429 FOOT DEFORMITY 59 0.0053
430 INCORRECT DOSE ADMINISTERED 1212 0.0053
431 BLOOD POTASSIUM INCREASED 86 0.0053
432 PRODUCT DISTRIBUTION ISSUE 49 0.0053
433 GASTRITIS 139 0.0053
434 IMPAIRED DRIVING ABILITY 60 0.0053
435 WRONG DRUG ADMINISTERED 47 0.0053
436 COUGH 1474 0.0053
437 SYSTEMIC LUPUS ERYTHEMATOSUS 186 0.0052
438 PRODUCT STORAGE ERROR 456 0.0052
439 OEDEMA PERIPHERAL 634 0.0052
440 CEREBROVASCULAR ACCIDENT 881 0.0052
441 MYASTHENIA GRAVIS 42 0.0052
442 PURPURA 46 0.0052
443 DISSEMINATED INTRAVASCULAR COAGULATION 73 0.0052
444 SPINAL DISORDER 49 0.0052
445 MUSCULOSKELETAL CHEST PAIN 80 0.0052
446 MICTURITION URGENCY 59 0.0052
447 MUSCULAR WEAKNESS 587 0.0052
448 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 53 0.0052
449 PRODUCT ODOUR ABNORMAL 54 0.0052
450 DIZZINESS 2566 0.0051
451 ATAXIA 61 0.0051
452 MUSCLE ATROPHY 65 0.0051
453 PHARMACEUTICAL PRODUCT COMPLAINT 133 0.0051
454 MUSCULOSKELETAL DISCOMFORT 88 0.0051
455 BACK DISORDER 83 0.0051
456 ASTHENIA 1919 0.0051
457 SWELLING FACE 332 0.0051
458 PRODUCT COMPLAINT 129 0.0051
459 GAIT INABILITY 170 0.0051
460 HOT FLUSH 382 0.0051
461 BLOOD IRON DECREASED 60 0.0051
462 POST PROCEDURAL COMPLICATION 97 0.0050
463 FEELING COLD 140 0.0050
464 HYPOMAGNESAEMIA 70 0.0050
465 ANGINA PECTORIS 144 0.0050
466 SCRATCH 53 0.0050
467 APHONIA 70 0.0050
468 DYSURIA 184 0.0050
469 INTERNAL HAEMORRHAGE 57 0.0050
470 BLISTER 280 0.0050
471 BLOOD CALCIUM DECREASED 56 0.0050
472 ASTHMA 562 0.0050
473 INITIAL INSOMNIA 51 0.0050
474 URINARY INCONTINENCE 147 0.0050
475 SMALL INTESTINAL OBSTRUCTION 61 0.0050
476 WEIGHT DECREASED 1383 0.0049
477 SKIN ULCER 128 0.0049
478 BLOOD COUNT ABNORMAL 75 0.0049
479 CONSTIPATION 1078 0.0049
480 ACCIDENT 59 0.0049
481 HYPOPHAGIA 126 0.0049
482 WHITE BLOOD CELL COUNT INCREASED 189 0.0049
483 RENAL FAILURE ACUTE 209 0.0049
484 PRODUCT DOSE OMISSION 321 0.0049
485 HYPOTHYROIDISM 157 0.0049
486 ULCER 78 0.0049
487 ACCIDENTAL EXPOSURE TO PRODUCT 505 0.0049
488 LACERATION 46 0.0049
489 CORONARY ARTERY OCCLUSION 67 0.0049
490 INTENTIONAL PRODUCT USE ISSUE 427 0.0049
491 SECRETION DISCHARGE 61 0.0049
492 LUNG INFILTRATION 43 0.0049
493 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 43 0.0049
494 PERIPHERAL SWELLING 749 0.0049
495 COAGULOPATHY 81 0.0049
496 PRURITUS GENERALISED 105 0.0049
497 CARDIAC DISORDER 453 0.0048
498 LOCALISED INFECTION 117 0.0048
499 INCONTINENCE 51 0.0048
500 CHEST DISCOMFORT 494 0.0048
501 DERMATITIS 101 0.0048
502 PRODUCT DOSE OMISSION ISSUE 1417 0.0048
503 MELAENA 106 0.0048
504 GASTROINTESTINAL HAEMORRHAGE 402 0.0048
505 SUPRAVENTRICULAR TACHYCARDIA 46 0.0048
506 LIP SWELLING 160 0.0048
507 HEADACHE 3009 0.0048
508 CARDIAC FAILURE 384 0.0048
509 BACK INJURY 52 0.0048
510 WEIGHT FLUCTUATION 50 0.0048
511 DEHYDRATION 637 0.0048
512 TOOTH DISORDER 106 0.0048
513 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 858 0.0048
514 GASTROOESOPHAGEAL REFLUX DISEASE 382 0.0047
515 CELLULITIS 238 0.0047
516 CYSTITIS 150 0.0047
517 ANAEMIA 896 0.0047
518 HAEMATEMESIS 119 0.0047
519 OSTEOPOROSIS 193 0.0047
520 PAIN IN EXTREMITY 1382 0.0047
521 WOUND 131 0.0047
522 URINARY RETENTION 156 0.0047
523 BACTERIAL INFECTION 87 0.0047
524 INFUSION SITE PAIN 60 0.0047
525 COLITIS ULCERATIVE 208 0.0046
526 NERVOUSNESS 243 0.0046
527 DRUG DISPENSING ERROR 71 0.0046
528 SKIN CANCER 100 0.0046
529 CARPAL TUNNEL SYNDROME 65 0.0046
530 RASH PAPULAR 104 0.0046
531 GAIT DISTURBANCE 888 0.0046
532 OSTEOMYELITIS 84 0.0046
533 POOR VENOUS ACCESS 48 0.0046
534 BRONCHOSPASM 66 0.0046
535 RESPIRATORY RATE INCREASED 41 0.0046
536 PNEUMONIA 1494 0.0046
537 CONTUSION 444 0.0046
538 PHARYNGITIS 57 0.0046
539 SPINAL FRACTURE 92 0.0046
540 ABDOMINAL DISCOMFORT 770 0.0046
541 PAIN IN JAW 130 0.0046
542 RENAL FAILURE 608 0.0046
543 OXYGEN SATURATION DECREASED 257 0.0046
544 HAEMOPTYSIS 127 0.0045
545 PRODUCT DISPENSING ERROR 99 0.0045
546 JOINT INJURY 97 0.0045
547 HYPOGLYCAEMIA 220 0.0045
548 CLOSTRIDIUM DIFFICILE COLITIS 48 0.0045
549 PERSONALITY CHANGE 42 0.0045
550 TENDONITIS 70 0.0045
551 SINUSITIS 463 0.0045
552 PULMONARY EMBOLISM 428 0.0045
553 CANDIDA INFECTION 76 0.0045
554 UNRESPONSIVE TO STIMULI 116 0.0045
555 LIMB DISCOMFORT 139 0.0045
556 RASH MACULAR 157 0.0045
557 DYSPNOEA 2540 0.0045
558 NECK PAIN 250 0.0045
559 PLEURAL EFFUSION 272 0.0045
560 CONDITION AGGRAVATED 1356 0.0045
561 RESTLESS LEGS SYNDROME 81 0.0044
562 JOINT DISLOCATION 47 0.0044
563 HYPERGLYCAEMIA 162 0.0044
564 PERIPHERAL COLDNESS 61 0.0044
565 LUNG INFECTION 69 0.0044
566 DIALYSIS 63 0.0044
567 HYPERSOMNIA 127 0.0044
568 FATIGUE 3447 0.0044
569 SLEEP DISORDER 312 0.0044
570 PRESYNCOPE 107 0.0044
571 ERUCTATION 85 0.0044
572 ORAL DISCOMFORT 61 0.0044
573 RENAL TUBULAR NECROSIS 43 0.0044
574 SOMNOLENCE 880 0.0044
575 HAEMATOMA 113 0.0044
576 CHOKING 85 0.0044
577 OEDEMA 236 0.0043
578 HAEMATURIA 149 0.0043
579 BLOOD CREATININE INCREASED 284 0.0043
580 MIGRAINE 415 0.0043
581 BLOOD THYROID STIMULATING HORMONE INCREASED 40 0.0043
582 PULMONARY FIBROSIS 83 0.0043
583 FLUID RETENTION 220 0.0043
584 FUNGAL INFECTION 144 0.0043
585 DISCOMFORT 262 0.0043
586 LETHARGY 247 0.0043
587 SKIN EXFOLIATION 362 0.0043
588 CIRCULATORY COLLAPSE 73 0.0043
589 SKIN IRRITATION 196 0.0043
590 SPEECH DISORDER 224 0.0043
591 NEUROPATHY PERIPHERAL 405 0.0043
592 CARDIOGENIC SHOCK 61 0.0042
593 GASTROENTERITIS 62 0.0042
594 HYPOTENSION 852 0.0042
595 ADVERSE DRUG REACTION 381 0.0042
596 DECREASED APPETITE 982 0.0042
597 COLON CANCER 63 0.0042
598 TENDERNESS 44 0.0042
599 SUBARACHNOID HAEMORRHAGE 43 0.0042
600 SPINAL OPERATION 52 0.0042
601 MUSCULOSKELETAL PAIN 221 0.0042
602 MYOCARDIAL ISCHAEMIA 48 0.0042
603 ANOSMIA 61 0.0042
604 PRURITUS 1618 0.0042
605 CEREBRAL HAEMORRHAGE 150 0.0042
606 NEPHROLITHIASIS 192 0.0042
607 KIDNEY INFECTION 82 0.0042
608 INTENTIONAL DOSE OMISSION 119 0.0042
609 RASH PRURITIC 226 0.0042
610 INFLAMMATION 215 0.0042
611 THROMBOSIS 335 0.0042
612 DISORIENTATION 165 0.0042
613 CHEST PAIN 769 0.0041
614 MUSCULOSKELETAL DISORDER 79 0.0041
615 THERAPY INTERRUPTED 296 0.0041
616 ARTHROPATHY 230 0.0041
617 EATING DISORDER 88 0.0041
618 TENDON RUPTURE 51 0.0041
619 MYALGIA 702 0.0041
620 SLUGGISHNESS 42 0.0041
621 OROPHARYNGEAL PAIN 381 0.0041
622 DYSSTASIA 120 0.0041
623 GAMMA-GLUTAMYLTRANSFERASE INCREASED 91 0.0041
624 DEPRESSION 933 0.0041
625 BACK PAIN 951 0.0041
626 FLATULENCE 232 0.0041
627 DYSPEPSIA 402 0.0041
628 INSOMNIA 1087 0.0041
629 BLOOD ALKALINE PHOSPHATASE INCREASED 101 0.0041
630 THERAPEUTIC PRODUCT EFFECT DECREASED 182 0.0041
631 BODY TEMPERATURE DECREASED 40 0.0041
632 FLUID OVERLOAD 59 0.0040
633 APPLICATION SITE PAIN 89 0.0040
634 BURSITIS 49 0.0040
635 COVID-19 707 0.0040
636 MEMORY IMPAIRMENT 553 0.0040
637 THERAPEUTIC RESPONSE UNEXPECTED 180 0.0040
638 SKIN LESION 110 0.0040
639 MASS 56 0.0040
640 CARDIOMYOPATHY 59 0.0040
641 DRUG EFFECT DECREASED 215 0.0040
642 HEART RATE INCREASED 395 0.0040
643 ACUTE MYOCARDIAL INFARCTION 117 0.0040
644 CHOLELITHIASIS 130 0.0040
645 NASOPHARYNGITIS 730 0.0040
646 ECONOMIC PROBLEM 60 0.0040
647 ORAL CANDIDIASIS 52 0.0039
648 MUSCLE TWITCHING 91 0.0039
649 FEEDING DISORDER 80 0.0039
650 SKIN FISSURES 77 0.0039
651 HERNIA 76 0.0039
652 INSURANCE ISSUE 60 0.0039
653 FEMUR FRACTURE 121 0.0039
654 RENAL DISORDER 182 0.0039
655 FOOT FRACTURE 74 0.0039
656 PHARYNGEAL OEDEMA 60 0.0039
657 EXPOSURE VIA SKIN CONTACT 101 0.0039
658 CONTRAINDICATED PRODUCT ADMINISTERED 118 0.0039
659 PRODUCT USE ISSUE 731 0.0039
660 GINGIVAL BLEEDING 53 0.0039
661 ANKLE FRACTURE 60 0.0039
662 PLATELET COUNT DECREASED 413 0.0039
663 TREMOR 643 0.0039
664 EAR INFECTION 103 0.0039
665 DIARRHOEA 2497 0.0039
666 SKIN DISORDER 129 0.0039
667 CYST 48 0.0039
668 LUNG DISORDER 188 0.0038
669 MUSCLE TIGHTNESS 62 0.0038
670 METABOLIC ACIDOSIS 122 0.0038
671 ISCHAEMIC STROKE 68 0.0038
672 PRESCRIBED UNDERDOSE 76 0.0038
673 DECREASED ACTIVITY 41 0.0038
674 BACTERAEMIA 45 0.0038
675 PNEUMOTHORAX 60 0.0038
676 JOINT STIFFNESS 99 0.0038
677 RENAL PAIN 40 0.0038
678 DEVICE USE ISSUE 66 0.0038
679 CHROMATURIA 85 0.0038
680 RASH ERYTHEMATOUS 180 0.0038
681 DYSKINESIA 153 0.0038
682 ABASIA 93 0.0038
683 MUSCLE SPASMS 690 0.0038
684 THERAPY CESSATION 193 0.0038
685 SPLENOMEGALY 44 0.0038
686 DEVICE FAILURE 57 0.0037
687 SURGERY 219 0.0037
688 NIGHT SWEATS 120 0.0037
689 PRODUCT PHYSICAL ISSUE 75 0.0037
690 INTENTIONAL PRODUCT MISUSE 325 0.0037
691 NEEDLE ISSUE 108 0.0037
692 TOOTHACHE 67 0.0037
693 UPPER RESPIRATORY TRACT INFECTION 171 0.0037
694 TOOTH EXTRACTION 46 0.0037
695 THIRST 66 0.0037
696 PLASMA CELL MYELOMA 144 0.0037
697 DRUG DOSE OMISSION 610 0.0037
698 IMPAIRED HEALING 121 0.0037
699 PNEUMONIA ASPIRATION 92 0.0037
700 PERICARDIAL EFFUSION 85 0.0037
701 THERAPY NON-RESPONDER 165 0.0037
702 RENAL INJURY 109 0.0037
703 HEMIPARESIS 62 0.0037
704 HERPES ZOSTER 210 0.0037
705 WHITE BLOOD CELL COUNT DECREASED 396 0.0036
706 RASH 1592 0.0036
707 DYSPHAGIA 346 0.0036
708 LIVER FUNCTION TEST ABNORMAL 106 0.0036
709 RESPIRATORY DISORDER 109 0.0036
710 LOSS OF CONSCIOUSNESS 466 0.0036
711 MALAISE 1595 0.0036
712 MENTAL STATUS CHANGES 101 0.0036
713 SWELLING 340 0.0036
714 BLOOD TRIGLYCERIDES INCREASED 64 0.0036
715 BLOOD BILIRUBIN INCREASED 97 0.0036
716 BONE DISORDER 65 0.0036
717 DRUG INTERACTION 565 0.0036
718 PANCREATITIS ACUTE 80 0.0036
719 INTESTINAL OBSTRUCTION 134 0.0036
720 HYPOXIA 125 0.0035
721 NEURALGIA 86 0.0035
722 HEPATIC ENZYME INCREASED 241 0.0035
723 PARAESTHESIA 554 0.0035
724 JOINT SWELLING 425 0.0035
725 CEREBRAL INFARCTION 86 0.0035
726 ABNORMAL DREAMS 97 0.0035
727 CYTOPENIA 43 0.0035
728 RESPIRATORY FAILURE 256 0.0035
729 IRRITABLE BOWEL SYNDROME 75 0.0035
730 GASTRIC DISORDER 120 0.0035
731 PARALYSIS 50 0.0035
732 LABORATORY TEST ABNORMAL 103 0.0035
733 PRODUCT PRESCRIBING ERROR 83 0.0035
734 LEUKOCYTOSIS 63 0.0035
735 NEOPLASM 40 0.0035
736 SEPSIS 386 0.0035
737 DYSARTHRIA 130 0.0035
738 OBESITY 55 0.0034
739 APHASIA 104 0.0034
740 INFLUENZA 384 0.0034
741 LOCAL SWELLING 60 0.0034
742 LOWER LIMB FRACTURE 66 0.0034
743 INTERVERTEBRAL DISC PROTRUSION 75 0.0034
744 SENSORY DISTURBANCE 55 0.0034
745 PARANOIA 59 0.0034
746 HYPOAESTHESIA 512 0.0034
747 BONE PAIN 200 0.0034
748 DRUG EFFECT INCOMPLETE 124 0.0034
749 ARTHRALGIA 1417 0.0034
750 APPLICATION SITE ERYTHEMA 89 0.0034
751 HAEMORRHAGE 354 0.0034
752 FEELING ABNORMAL 811 0.0034
753 UNEVALUABLE EVENT 256 0.0034
754 HYPOKINESIA 49 0.0034
755 GLYCOSYLATED HAEMOGLOBIN INCREASED 85 0.0034
756 GASTRIC ULCER 64 0.0034
757 AMNESIA 219 0.0034
758 GALLBLADDER DISORDER 60 0.0034
759 APATHY 49 0.0034
760 APPLICATION SITE PRURITUS 76 0.0033
761 INTERSTITIAL LUNG DISEASE 162 0.0033
762 MUSCULOSKELETAL STIFFNESS 293 0.0033
763 POOR QUALITY SLEEP 72 0.0033
764 BLOOD CREATINE PHOSPHOKINASE INCREASED 96 0.0033
765 DIABETES MELLITUS INADEQUATE CONTROL 59 0.0033
766 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 237 0.0033
767 STOMATITIS 202 0.0033
768 MOBILITY DECREASED 239 0.0033
769 LYMPHOPENIA 47 0.0033
770 HYPERCALCAEMIA 41 0.0033
771 CHILLS 389 0.0033
772 HYPOCALCAEMIA 62 0.0033
773 RENAL IMPAIRMENT 275 0.0033
774 MOVEMENT DISORDER 105 0.0033
775 PAIN 2005 0.0033
776 SARS-COV-2 TEST POSITIVE 43 0.0033
777 OFF LABEL USE 2848 0.0032
778 EXTRA DOSE ADMINISTERED 131 0.0032
779 ORAL HERPES 63 0.0032
780 ASPARTATE AMINOTRANSFERASE INCREASED 171 0.0032
781 THERAPY PARTIAL RESPONDER 50 0.0032
782 FEAR 86 0.0032
783 BLOOD GLUCOSE INCREASED 600 0.0032
784 KNEE ARTHROPLASTY 67 0.0032
785 MYELODYSPLASTIC SYNDROME 46 0.0032
786 ABDOMINAL PAIN UPPER 654 0.0032
787 PYREXIA 1096 0.0032
788 RASH GENERALISED 82 0.0032
789 CLOSTRIDIUM DIFFICILE INFECTION 69 0.0032
790 MYOCARDIAL INFARCTION 551 0.0032
791 BLOOD TEST ABNORMAL 44 0.0031
792 ALOPECIA 614 0.0031
793 TREATMENT NONCOMPLIANCE 171 0.0031
794 DIABETIC KETOACIDOSIS 75 0.0031
795 HEPATIC STEATOSIS 58 0.0031
796 TACHYCARDIA 276 0.0031
797 FEELING HOT 190 0.0031
798 COLITIS 117 0.0031
799 PNEUMONITIS 84 0.0031
800 DELIRIUM 107 0.0031
801 GLOSSODYNIA 69 0.0031
802 PRODUCT PRESCRIBING ISSUE 67 0.0031
803 VIRAL INFECTION 102 0.0031
804 FRACTURE 58 0.0031
805 RETCHING 65 0.0030
806 GENERAL PHYSICAL HEALTH DETERIORATION 352 0.0030
807 LYMPHOMA 47 0.0030
808 NO ADVERSE EVENT 550 0.0030
809 DRUG EXPOSURE DURING PREGNANCY 103 0.0030
810 VENTRICULAR TACHYCARDIA 50 0.0030
811 ABDOMINAL DISTENSION 316 0.0030
812 PRODUCT USE IN UNAPPROVED INDICATION 750 0.0030
813 NAUSEA 2391 0.0030
814 DRY SKIN 403 0.0030
815 ALANINE AMINOTRANSFERASE INCREASED 185 0.0030
816 RESPIRATORY DISTRESS 83 0.0030
817 DEPRESSED MOOD 158 0.0030
818 CYANOSIS 47 0.0030
819 JOINT RANGE OF MOTION DECREASED 40 0.0030
820 COMA 142 0.0030
821 QUALITY OF LIFE DECREASED 40 0.0030
822 PARAESTHESIA ORAL 43 0.0030
823 SCAR 51 0.0030
824 STAPHYLOCOCCAL INFECTION 98 0.0030
825 TYPE 2 DIABETES MELLITUS 100 0.0030
826 ROAD TRAFFIC ACCIDENT 124 0.0030
827 THROAT TIGHTNESS 80 0.0030
828 THINKING ABNORMAL 55 0.0029
829 FLUSHING 300 0.0029
830 INJURY ASSOCIATED WITH DEVICE 60 0.0029
831 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 50 0.0029
832 FEELING JITTERY 56 0.0029
833 DEATH 2530 0.0029
834 COGNITIVE DISORDER 137 0.0029
835 ACTIVITIES OF DAILY LIVING IMPAIRED 58 0.0029
836 MENTAL IMPAIRMENT 71 0.0029
837 DEVICE RELATED INFECTION 45 0.0029
838 FIBROMYALGIA 71 0.0029
839 HYPOAESTHESIA ORAL 44 0.0029
840 DISEASE PROGRESSION 345 0.0029
841 DEVICE OCCLUSION 41 0.0029
842 NEOPLASM MALIGNANT 194 0.0029
843 ANXIETY 827 0.0029
844 PANCYTOPENIA 162 0.0029
845 MOUTH ULCERATION 61 0.0029
846 COORDINATION ABNORMAL 40 0.0029
847 FACE OEDEMA 48 0.0028
848 WEIGHT INCREASED 635 0.0028
849 ACUTE RESPIRATORY DISTRESS SYNDROME 50 0.0028
850 ASCITES 83 0.0028
851 DRUG PRESCRIBING ERROR 54 0.0028
852 LACTIC ACIDOSIS 91 0.0028
853 HIP ARTHROPLASTY 43 0.0028
854 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 154 0.0028
855 HYPERHIDROSIS 361 0.0028
856 PALLOR 76 0.0028
857 VOMITING 1312 0.0028
858 PANIC ATTACK 101 0.0028
859 DRUG EFFECT LESS THAN EXPECTED 41 0.0028
860 PROCEDURAL PAIN 76 0.0027
861 ILLNESS 281 0.0027
862 LIVER FUNCTION TEST INCREASED 58 0.0027
863 BODY TEMPERATURE INCREASED 55 0.0027
864 ABSCESS 43 0.0027
865 PROTEINURIA 51 0.0027
866 BRAIN FOG 42 0.0027
867 OSTEONECROSIS OF JAW 66 0.0027
868 DISEASE RECURRENCE 126 0.0026
869 ENCEPHALOPATHY 65 0.0026
870 ABDOMINAL PAIN 615 0.0026
871 EJECTION FRACTION DECREASED 41 0.0026
872 ANHEDONIA 69 0.0026
873 INCORRECT PRODUCT ADMINISTRATION DURATION 56 0.0026
874 GASTROINTESTINAL DISORDER 230 0.0026
875 INCREASED APPETITE 49 0.0026
876 AGITATION 187 0.0025
877 BLOOD GLUCOSE DECREASED 122 0.0025
878 ABNORMAL BEHAVIOUR 100 0.0025
879 HEPATIC CIRRHOSIS 47 0.0025
880 GASTROENTERITIS VIRAL 45 0.0025
881 SHOCK 57 0.0025
882 DISABILITY 49 0.0025
883 DEPRESSED LEVEL OF CONSCIOUSNESS 98 0.0025
884 RHEUMATOID ARTHRITIS 281 0.0025
885 RHABDOMYOLYSIS 103 0.0025
886 THROMBOCYTOPENIA 276 0.0025
887 LYMPHADENOPATHY 87 0.0025
888 NEUTROPHIL COUNT DECREASED 99 0.0024
889 LIVER DISORDER 107 0.0024
890 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 62 0.0024
891 INFECTION 348 0.0024
892 CYTOKINE RELEASE SYNDROME 48 0.0024
893 METASTASES TO LIVER 42 0.0024
894 RASH MACULO-PAPULAR 53 0.0024
895 DEVICE MALFUNCTION 166 0.0024
896 CARDIAC ARREST 195 0.0024
897 LEUKOPENIA 117 0.0023
898 STEVENS-JOHNSON SYNDROME 52 0.0023
899 PRESCRIBED OVERDOSE 45 0.0023
900 CARDIOVASCULAR DISORDER 59 0.0023
901 INFLUENZA LIKE ILLNESS 191 0.0023
902 URTICARIA 386 0.0023
903 LOWER RESPIRATORY TRACT INFECTION 104 0.0023
904 DEVICE DISLOCATION 99 0.0023
905 COLD SWEAT 40 0.0023
906 HOSPITALISATION 347 0.0023
907 UNDERDOSE 163 0.0022
908 MENTAL DISORDER 97 0.0022
909 FEBRILE NEUTROPENIA 147 0.0022
910 PANCREATITIS 117 0.0022
911 RESTLESSNESS 81 0.0022
912 HEPATIC FUNCTION ABNORMAL 82 0.0022
913 NEOPLASM PROGRESSION 76 0.0022
914 INJURY 153 0.0022
915 ABDOMINAL PAIN LOWER 55 0.0022
916 ADVERSE EVENT 200 0.0022
917 EPILEPSY 66 0.0022
918 MULTIPLE SCLEROSIS 103 0.0022
919 DISTURBANCE IN ATTENTION 116 0.0021
920 DEVICE DELIVERY SYSTEM ISSUE 58 0.0021
921 JAUNDICE 57 0.0021
922 AGGRESSION 106 0.0021
923 SEPTIC SHOCK 90 0.0021
924 ILL-DEFINED DISORDER 125 0.0021
925 ELECTROCARDIOGRAM QT PROLONGED 74 0.0021
926 INTENTIONAL DRUG MISUSE 43 0.0021
927 INFUSION RELATED REACTION 136 0.0020
928 SEIZURE 237 0.0020
929 PREGNANCY 41 0.0020
930 ALTERED STATE OF CONSCIOUSNESS 44 0.0020
931 NEUTROPENIA 276 0.0020
932 MOOD ALTERED 55 0.0020
933 MULTIPLE ORGAN DYSFUNCTION SYNDROME 57 0.0020
934 ANGIOEDEMA 89 0.0020
935 DRUG-INDUCED LIVER INJURY 62 0.0020
936 LUNG NEOPLASM MALIGNANT 81 0.0020
937 IRRITABILITY 118 0.0020
938 PREMATURE BABY 58 0.0019
939 INJECTION SITE HAEMORRHAGE 153 0.0019
940 DEVICE ISSUE 168 0.0019
941 CARDIO-RESPIRATORY ARREST 78 0.0019
942 PROSTATE CANCER 149 0.0019
943 FOETAL EXPOSURE DURING PREGNANCY 147 0.0018
944 NERVOUS SYSTEM DISORDER 56 0.0018
945 THERAPEUTIC RESPONSE SHORTENED 59 0.0018
946 INCORRECT DOSE ADMINISTERED BY DEVICE 46 0.0018
947 ANAPHYLACTIC SHOCK 45 0.0017
948 CRYING 63 0.0017
949 HEPATITIS 44 0.0017
950 MOOD SWINGS 54 0.0017
951 EXPOSURE DURING PREGNANCY 105 0.0017
952 ANAPHYLACTIC REACTION 92 0.0017
953 INJECTION SITE BRUISING 132 0.0017
954 EMOTIONAL DISORDER 51 0.0017
955 SUICIDAL IDEATION 150 0.0016
956 PSORIASIS 209 0.0016
957 PSORIATIC ARTHROPATHY 64 0.0016
958 DERMATITIS ATOPIC 83 0.0016
959 INCORRECT DRUG ADMINISTRATION DURATION 44 0.0016
960 PAIN OF SKIN 42 0.0016
961 INJECTION SITE PAIN 474 0.0015
962 CONVULSION 88 0.0015
963 SKIN BURNING SENSATION 110 0.0015
964 MALIGNANT NEOPLASM PROGRESSION 156 0.0015
965 ACNE 115 0.0015
966 PSYCHOTIC DISORDER 44 0.0015
967 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 69 0.0015
968 HEPATIC FAILURE 44 0.0015
969 BREAST CANCER 134 0.0014
970 MULTIPLE SCLEROSIS RELAPSE 98 0.0014
971 EMOTIONAL DISTRESS 169 0.0014
972 BONE DENSITY DECREASED 43 0.0014
973 VAGINAL HAEMORRHAGE 59 0.0014
974 DEVICE BREAKAGE 54 0.0013
975 OSTEONECROSIS 43 0.0013
976 OVERDOSE 279 0.0013
977 ANGER 43 0.0013
978 INJECTION SITE SWELLING 97 0.0013
979 INJECTION SITE ERYTHEMA 149 0.0012
980 INJECTION SITE PRURITUS 78 0.0012
981 INJECTION SITE REACTION 79 0.0011
982 INCORRECT ROUTE OF DRUG ADMINISTRATION 40 0.0011
983 INJECTION SITE MASS 41 0.0011
984 DEVICE LEAKAGE 48 0.0011
985 ABORTION SPONTANEOUS 42 0.0010
986 MATERNAL EXPOSURE DURING PREGNANCY 89 0.0010
987 DEVICE DIFFICULT TO USE 66 0.0010
988 BLADDER CANCER 55 0.0009
989 TOXICITY TO VARIOUS AGENTS 143 0.0008
990 SUICIDE ATTEMPT 50 0.0008
991 DRUG DEPENDENCE 57 0.0004